Open AccessA network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension
Author(s) -
Yijing Zhang,
Na Wang,
ZhiChun Gu,
Anhua Wei,
An-Ni Cheng,
Shasha Fang,
Hongli Du,
Linzhao Wang,
Guoqing Zhang
Publication year - 2019
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt.2019.03.02
Subject(s) - ambrisentan , bosentan , medicine , peripheral edema , endothelin receptor , liver function , placebo , meta analysis , cardiology , gastroenterology , adverse effect , pathology , receptor , alternative medicine
Currently, direct comparative safety between endothelin receptor antagonists (ERAs) in pulmonary arterial hypertension (PAH) is limited. Thus, a systematic review with network analysis was conducted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom